1.Evaluation of dengue IgA antibody and NS1 antigen rapid tests as early diagnostic tests for dengue virus infection
Christine Listyawati Irianto ; Grace Devota G. Go
Pediatric Infectious Disease Society of the Philippines Journal 2014;15(1):9-14
BACKGROUND: Dengue is a major health problem. The lack of data on the usefulness of rapid diagnostic tests for early detection of dengue has generated interest in determining their validity.
OBJECTIVES: This research aimed to determine the validity of dengue IgA antibody versus NS1 antigen test as rapid diagnostic tests for early detection of dengue using Hemagglutination Inhibition test (HI) as standard reference.
METHODOLOGY: This study included 51 pediatric patients being evaluated for dengue in a private hospital from March 01, 2012 to October 30, 2012. Paired serum samples from patients suspected of dengue and had fever of not more than seven days were examined. Initial blood samples were collected on the first day of consult and tested for dengue IgA antibody, dengue NS1 antigen, and dengue HI tests. Second blood samples for HI were collected seven days after the initial extraction
RESULTS: The 51 serum samples used in this study came from 29 males and 22 females. From these samples, sensitivity of dengue IgA antibody was 80% with 95% CI (70-90) while specificity was at 50% with 95% CI(34-64) while dengue NS1 antigen which showed sensitivity of 27% with 95% CI (15-39) and specificity of 67% with 95% CI (54-86). IgA rapid test demonstrated 71% positivity in detecting acute primary dengue infection and 82% for acute secondary infection. NS1 detected 43% of primary infection and 24% of secondary infection.
CONCLUSION: Dengue IgA antibody rapid test was more sensitive than NS1 antigen test for early diagnosis of dengue and had better performance in detecting primary and secondary dengue.
Human ; Male ; Female ; Adolescent ; Child ; Child Preschool ; Dengue-diagnosis, Diagnostic Techniques and Procedures ; Immunoglobulin A ; Antigens ; Hemagglutination Inhibition Tests
2.Clinical practice guidelines on leptospirosis in children 2019
Maria Anna P. Bañ ; ez, M.D ; Melba V. Marasigan, M.D. ; Ma. Liza Antoinette M. Gonzales, M.D., MSc ; Grace Devota G. Go, M.D. ; Fatima I. Gimenez, M.D. ; Mary Antonette C. Madrid, M.D. ; John Andrew T. Camposano, M.D. ; Jennifer M. Nailes, M.D., MSPH ; Ma. Lucila M. Perez, M.D., MSc
Pediatric Infectious Disease Society of the Philippines Journal 2023;24(1):5-69
Executive Summary
Leptospirosis is a disease prevalent mostly in tropical and subtropical countries. Its potential to be a concerning
problem emerges with the onset of the rainy season, as flooding and heavy rainfall facilitate disease epidemics. Among
those at risk of contracting the disease are field workers, veterinarians, sewer workers, military personnel and those
who swim or wade in contaminated waters.
In the absence of an existing evidence-based guideline for the pediatric age group, this first edition hopes to
standardize approach to diagnosis, antibiotic management, and prevention of leptospirosis. The intended users are
primary care physicians, family medicine physicians, pediatricians, and other healthcare workers involved in the
management of leptospirosis in children.
Ten priority questions were identified by a group of experts composed of an oversight committee, a guideline
writing panel, and a technical review committee. The GRADE methodology was used to determine the quality of
evidence of each recommendation. The draft recommendations (summarized below) were finalized after these were
presented to and voted on by a panel of stakeholders.